Chindarat Natejumnong MD*, Prajej Ruangkanchanasetr MD*, Pote Aimpun MD, PhD*, Thanom Supaporn MD*
Affiliation : * Division of Nephrology, Phramongkutklao Hospital ** Department of Military and Community Medicine, Phramongkutklao Hospital
Background : Some autoantibodies have been associated with lupus nephritis but the role of antiphospholipid
antibodies (APA) is controversial.
Objective : The present study was to explore the role of APA by comparing demographic profiles and the
presence of anticardiolipin antibody (aCL) and lupus anticoagulant (LA) in systemiclupus erythematosus
(SLE) patients with and without nephritis.
Materials and Methods : The cross-sectional study in a tertiary center was conducted in 77 SLE patients. All
patients attended our renal or rheumatology clinics between June 2002 and December 2003.
Results : Sixty-three (82%) of the 77 SLE patients had nephritis. The prevalence of antiphospholipid syndrome
(APS) was 10% (8 patients), positive aCL (IgG) was 26% (20 patients) and positive LA was 26% (20 pa-
tients). The receiver operating characteristic (ROC) method was applied to assess the significance of aCL in
both nephritis and non-nephritis groups. Area under the ROC curve was 0.538 (95%CI 0.312-0.765), a cutoff
value of 20.5 GPL had a sensitivity of 75% and a specificity of 53%. In univariate analysis, neither positivity
for anticardiolipin antibody nor lupus anticoagulant was associated with lupus nephritis. Analyzed in only
the lupus nephritis group, LA-positive lupus nephritis patients had higher systolic blood pressure (SBP)
(133.7 vs 121.9 mmHg, p = 0.005), lower platelet count (209.8 vs 264.4 x 103/µL, p = 0.02) and higher 24-hr
urine protein excretion (2.6 vs 1.4 g, p = 0.02) than LA-negative lupus nephritis patients. Serum creatinine
was higher in LA-positive lupus nephritis than LA-negative (233.0 vs 94.9 µmol/L), but did not reach statisti-
cal significance.
Conclusion : APA are frequently seen in SLE patients, but not associated with lupus nephritis. However, lupus
anticoagulant tends to associate with lupus nephritis. Detection of LA in lupus nephritis patients could
identify patients who had increased risk to develop bad renal outcomes (elevated SBP and 24-hr urine protein
excretion).
Keywords : Antiphospholipid antibodies, Lupus nephritis, Antiphospholipid syndrome
JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com
» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement
» Journal Sponsorship » Site Map » About this Publishing System
© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.